Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|June 29, 2026
Targeting Bruton tyrosine kinase with acalabrutinib attenuates murine sclerodermatous chronic graft versus host diseaseVasantharaja Raguraman, Miranda Mysinger, Mohit Verma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndromeGerhard C Hildebrandt, Krystyna M Olkiewicz, Leigh Corrion, et al.
Transplantation and Cellular Therapy|July 30, 2023
Role of Defibrotide in the Prevention of Murine Model Graft-versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationSenthilnathan Palaniyandi, Reena Kumari, Ethan Strattan, et al.
Hematology/Oncology and Stem Cell Therapy|February 6, 2018
Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohortHayder Saeed, Swati Yalamanchi, Meng Liu, et al.
Pulmonary Circulation|June 3, 2016
Pulmonary arterial hypertension in primary amyloidosisMeghan M Cirulis, Lyska L Emerson, David A Bull, et al.
Hematology/Oncology and Stem Cell Therapy|October 21, 2019
Ten-year survival outcomes for patients with early stage classical Hodgkin lymphoma: An analysis from Kentucky Cancer RegistryZin W Myint, Runa Shrestha, Salahuddin Siddiqui, et al.
Cytokine|September 2, 2009
G to C transition at position -173 of MIF gene of the recipient is associated with reduced relapse rates after allogeneic stem cell transplantationYa-Yi Chang, Hildegard T Greinix, Anne M Dickinson, et al.
Blood|November 18, 2004
Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantationGerhard C Hildebrandt, Krystyna M Olkiewicz, Sung Choi, et al.
Frontiers in Immunology|November 5, 2019
Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host DiseaseEthan Strattan, Senthilnathan Palaniyandi, Reena Kumari, et al.
International Journal of Hematology|March 17, 2009
Preventive usage of broad spectrum chemokine inhibitor NR58-3.14.3 reduces the severity of pulmonary and hepatic graft-versus-host diseaseSandra Miklos, Gunnar Mueller, Yayi Chang, et al.
Pageof 11